Bilimoria Karl Y, Cambic Angela, Hansen Nora M, Bethke Kevin P
Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Arch Surg. 2007 May;142(5):441-5; discussion 445-7. doi: 10.1001/archsurg.142.5.441.
Women with newly diagnosed breast cancers may harbor additional ipsilateral or contralateral breast malignancies that are undetected by mammography and ultrasonography. Magnetic resonance imaging (MRI) has demonstrated excellent sensitivity in the detection of breast cancers. However, the impact of routine MRI on the surgical management of new, biopsy-proven breast cancers remains unclear.
Retrospective analysis of a prospective database.
An academic, tertiary care center in a large metropolitan area.
A total of 155 women with breast cancer newly diagnosed by mammography, ultrasonography, and needle biopsy underwent preoperative bilateral breast MRI in a single-institution, single-surgeon setting during 1 year.
Change in surgical management based on breast MRI findings.
The MRI demonstrated 124 additional suspicious lesions in 73 patients. Post-MRI follow-up mammograms or ultrasonograms were required in 65 patients, and 41 patients underwent additional image-guided biopsies. There was a change in surgical management as MRI discovered additional, otherwise undetected malignancies in 36 patients based on radiographic-pathologic correlation. Lumpectomy was converted to mastectomy in 10 patients (8 beneficial), wider excision was performed in 21 patients (10 beneficial), and 5 patients (2 beneficial) underwent contralateral surgery. Larger tumor size was an independent predictor of a beneficial change in surgical management (odds ratio, 1.66; 95% confidence interval, 1.04-2.66).
Breast MRI results in a beneficial change in surgical management in 9.7% of newly diagnosed breast cancers. The detection of additional, otherwise undetected ipsilateral and contralateral breast malignancies with MRI suggests that breast MRI may have a role in the evaluation of new breast cancers.
新诊断出乳腺癌的女性可能存在其他未被乳腺X线摄影和超声检查发现的同侧或对侧乳腺恶性肿瘤。磁共振成像(MRI)在检测乳腺癌方面已显示出极高的灵敏度。然而,常规MRI对新确诊且经活检证实的乳腺癌手术治疗的影响仍不明确。
对前瞻性数据库进行回顾性分析。
一个大城市地区的学术性三级医疗中心。
在1年时间里,共有155名经乳腺X线摄影、超声检查和针吸活检新诊断出乳腺癌的女性,在单一机构、由单一外科医生进行了术前双侧乳腺MRI检查。
基于乳腺MRI检查结果的手术治疗变化。
MRI在73名患者中发现了124个额外的可疑病变。65名患者需要进行MRI检查后的乳腺X线摄影或超声检查随访,41名患者接受了额外的影像引导下活检。基于影像学 - 病理学相关性,MRI发现了额外的、原本未被检测到的恶性肿瘤,导致36名患者的手术治疗发生了改变。10名患者(8名受益)的保乳手术改为乳房切除术,21名患者(10名受益)进行了更广泛的切除,5名患者(2名受益)接受了对侧手术。肿瘤较大是手术治疗发生有益改变的独立预测因素(优势比,1.66;95%置信区间,1.04 - 2.66)。
乳腺MRI使9.7%的新诊断乳腺癌患者的手术治疗发生了有益改变。MRI检测出额外的、原本未被发现的同侧和对侧乳腺恶性肿瘤,表明乳腺MRI可能在新诊断乳腺癌的评估中发挥作用。